A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 378
Comprehensive Pages
- 35
Competitors Profiled
- 11
IOL Categories Forecasted
- 8
Geographic and Economic Breakouts
2025 IOL Market Report: Global Analysis for 2024 to 2030, March, 2025
The “2025 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 12 categories of IOLs: commodity monofocal, enhanced monofocal, intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, post-op adjustable, and phakic IOLs. Additionally, 35 companies are profiled, with discussion of their products, strategic market position, background, and outlook.
Latest Industry News & Trends
2/13/2026
BreakingCataractDealsIOLPrivate EquitySurgical
Belgian Company Invests 500 Million Euros for 45 Percent Stake in Rayner
Belgian investment company Groupe Bruxelles Lambert (GBL) reported Feb. 9 that it would invest 500 million euros (US $594 million, calculated on Feb. 11, 2026) in UK-based ophthalmic company Rayner...
2/12/2026
BiosimilarsBreakingDiagnosticIOLLaserRetinaRevenueThyroid Eye Disease
2025 and Quarterly Ophthalmic Revenue Roundup for Amgen, Santen, Hoya, Lumibird, and Ocular Therapeutix
Amgen, of Thousand Oaks, California, reported Feb. 3 that its 2025 revenue for Tepezza was $1.90 billion, a 3 percent increase over $1.85 billion in 2024, primarily driven by higher net selling pri...
2/12/2026
BreakingPharmaRegulation
New US Law Institutes Major Pharmacy Benefit Manager Reforms in 2029
The $1.2 trillion US spending package signed into law on Feb. 3 includes major reforms to pharmacy benefit manager (PBM) practices. These provisions go into effect for health plan years that come a...
2/13/2026
BiosimilarsBreakingDealsRetina
Samsung Bioepis’ Deals with Regeneron Clear Way for Eylea Biosimilar in US, Other Markets
Samsung Bioepis reported Feb. 12 that it had reached a settlement and license agreement with Regeneron that will allow its biosimilar to Eylea, branded Opuviz, to be launched in the US in January 2...
2/12/2026
BreakingDry EyeEurope
Nordic Pharma Launches Lacrifill Canalicular Gel for Dry Eye in Europe
Dutch drugmaker Nordic Pharma announced Feb. 5 the European launch of Lacrifill canalicular gel for dry eye. The treatment gained CE marking in April 2025. Lacrifill is a cross-linked hyaluronic ac...
2/13/2026
BreakingDiagnosticOptometry
American College of Eye Technicians Offers Fast-Track Virtual Training Program
The American College of Eye Technicians (ACET) recently opened enrollment for its fast-track virtual training program, an eight-week session that combines interactive activities and coursework to p...
2/12/2026
BreakingDealsGene TherapyRetina
MeiraGTx Licenses ZipBio’s Protein Therapeutic Technology for GA
MeiraGTx has obtained exclusive rights to protein therapeutic technology for geographic atrophy (GA) from ZipBio, the companies announced Feb. 3. The agreement includes an upfront payment, as well ...
2/12/2026
BreakingChinaDealsIOLRefractiveSurgical
Arctic Vision to Acquire MDCO Technology’s Ophthalmic Device Business
China’s Arctic Vision announced Feb. 2 that it would acquire the ophthalmic device business of MDCO Technology. Arctic Vision said MDCO markets a premium intraocular lens (IOL), a phakic lens, and ...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.